Chinese Biopharma Firms Chase Hong Kong IPO, After Duality’s Sizzling Debut

All NewsApril 24, 2025

Chinese biopharma firms are actively pursuing Hong Kong IPOs, following the strong debut of Duality Biotherapeutics earlier this month.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Chinese Biopharma Firms Chase Hong Kong IPO, After Duality’s Sizzling Debut

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

Amazon has a highly rated tennis bracelet for only $21

The beginning of the end of the age of Trump

The party’s over for the Trumpsterz

Circle’s ARC token sale lifts earnings as lower yields weigh on USDC income

Jack Dorsey’s Block (XYZ) Sets Aside $764 Million for DOJ Settlement as Bitcoin Profit Halves